From Seekingalpha · SA Transcripts · · 30s
Medifast Q3 2026 Earnings Call
Medifast CEO Nick Johnson details Q3 2026 financial results during earnings call.
In brief
Medifast CEO Nick Johnson details Q3 2026 financial results during earnings call. Medifast reported Q3 2026 earnings with CEO Nick Johnson and CFO Jim Maloney addressing financial performance. Originally reported by Seekingalpha.
Earnings Call Start
Medifast CEO Nick Johnson and CFO Jim Maloney begin Q3 2026 earnings call.
Earnings Release Available
Earnings release for Q3 2026 ended September 30, 2026 available on Medifast's website.
Forward-Looking Statements
Call includes forward-looking statements about future performance with risk disclosures.
What it means
Medifast reported Q3 2026 earnings with CEO Nick Johnson and CFO Jim Maloney addressing financial performance.
